thecloroxco_8k.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
——————————
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): November 17, 2010
 
THE CLOROX COMPANY
(Exact name of registrant as specified in its charter)
 
——————————
 
Delaware 1-07151 31-0595760
(State or other jurisdiction of (Commission File Number) (I.R.S. Employer
incorporation)   Identification No.)

1221 Broadway, Oakland, California 94612-1888
(Address of principal executive offices)     (Zip code)
 
(510) 271-7000
(Registrant's telephone number, including area code)
 
Not applicable
(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
[    ] Written communications pursuant to Rule 425 Under the Securities Act (17 CFR 230.425)
 
[    ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
[    ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
[    ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

Item 5.07 Submission of Matters to a Vote of Security Holders.
 
     On November 17, 2010, The Clorox Company (the “Company”) held its annual meeting of stockholders in San Ramon, California. The matters voted on and the results of the vote were as follows:
 
1. Our stockholders re-elected the following directors to each serve until the next Annual Meeting of Stockholders or until a successor is duly elected and qualified.
         
    Number of Votes
        For       Against       Abstain       Broker Non-Votes
Daniel Boggan, Jr.   93,070,953   917,031   140,233   25,765,689
Dr. Richard H. Carmona   93,402,384   595,400   130,433   25,765,689
Tully M. Friedman   92,457,364   1,545,016   125,837   25,765,689
George J. Harad   93,463,416   508,531   156,270   25,765,689
Donald R. Knauss   91,659,481   2,329,026   139,710   25,765,689
Robert W. Matschullat   93,045,684   939,376   143,157   25,765,689
Gary G. Michael   93,410,478   562,071   155,668   25,765,689
Edward A. Mueller   92,105,253   1,872,193   150,771   25,765,689
Jan L. Murley   93,542,563   433,111   152,543   25,765,689
Pamela Thomas-Graham   93,604,844   369,781   153,592   25,765,689
Carolyn M. Ticknor   93,702,480   283,797   141,940   25,765,689

2. Our stockholders ratified the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending June 30, 2011.
         
Number of Votes
For       Against       Abstain       Broker Non-Votes
119,193,695   439,262   260,949   0

3. Our stockholders approved the material terms of the performance goals under the Company’s 2005 Stock Incentive Plan.
         
Number of Votes
For       Against       Abstain       Broker Non-Votes
82,905,000   10,926,768   296,449   25,765,689

4. Our stockholders approved the material terms of the performance goals under the Company’s Executive Incentive Compensation Plan.
         
Number of Votes
For       Against       Abstain       Broker Non-Votes
84,497,919   9,330,111   300,187   25,765,689

 

5. Our stockholders voted against the stockholder proposal to amend the Company’s Bylaws to separate the roles of Chairman of the Board and Chief Executive Officer.
         
Number of Votes
For       Against       Abstain       Broker Non-Votes
24,410,495   68,338,940   1,378,782   25,765,689

 

SIGNATURES
 
     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
   
THE CLOROX COMPANY
       
Date: November 19, 2010   By:       /s/ Laura Stein
         Senior Vice President –
         General Counsel